Formosa Laboratories Inc
TWSE:4746

Watchlist Manager
Formosa Laboratories Inc Logo
Formosa Laboratories Inc
TWSE:4746
Watchlist
Price: 73.6 TWD 0.96% Market Closed
Market Cap: 8.9B TWD

Formosa Laboratories Inc's latest stock split occurred on Mar 5, 2020

The company executed a 1949-for-1934 stock split, meaning that for every 1934 shares held, investors received 1949 new shares.

Before the split, Formosa Laboratories Inc traded at 42.225 per share. Afterward, the share price was about 40.3124.

The adjusted shares began trading on Mar 5, 2020. This was Formosa Laboratories Inc's 3rd stock split, following the previous one in Jul 5, 2018.

Last Splits:
Mar 5, 2020
1949-for-1934
Jul 5, 2018
1021-for-1018
Aug 20, 2013
1382-for-1365
Pre-Split Price
40.1686 42.225
Post-Split Price
40.3124
Before
After
Last Splits:
Mar 5, 2020
1949-for-1934
Jul 5, 2018
1021-for-1018
Aug 20, 2013
1382-for-1365

Formosa Laboratories Inc
Stock Splits History

Formosa Laboratories Inc Stock Splits Timeline
Mar 5, 2020
Mar 5, 2020
Split 1949-for-1934
x1.0077559462254
Pre-Split Price
40.1686 42.225
Post-Split Price
40.3124
Before
After
Jul 5, 2018
Jul 5, 2018
Split 1021-for-1018
x1.0029469548134
Pre-Split Price
48.6174 53.9728
Post-Split Price
48.5153
Before
After
Aug 20, 2013
Aug 20, 2013
Split 1382-for-1365
x1.0124542124542
Pre-Split Price
47.3742 58.5336
Post-Split Price
45.8006
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Mar 18, 2025
Worksport Ltd
NASDAQ:WKSP
1-for-10
/10
0.0348 0.3477 USD 3.76 3.76 USD
Mar 18, 2025
NAYA Biosciences Inc
NASDAQ:NAYA
1-for-12
/12
0.2 2.4 USD 2.46 2.46 USD
Mar 17, 2025
Beijing Compass Technology Development Co Ltd
SZSE:300803
1-for-1
x1
92.86 64.0414 CNY 64.31 64.31 CNY
Mar 17, 2025
L
Luxxu Group Ltd
HKEX:1327
326-for-313
x1.0415335463259
0.163 0.1565 HKD 0.157 0.157 HKD
Mar 17, 2025
Workhorse Group Inc
NASDAQ:WKHS
1-for-12
/12
0.208 2.6 USD 2.03 2.03 USD
Load More

Formosa Laboratories Inc
Glance View

Market Cap
8.9B TWD
Industry
Pharmaceuticals

Formosa Laboratories, Inc. engages in the research and development of biotechnology new drugs. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2009-11-27. The firm primarily provides UV-proof active ingredients series products, vitamin D derivative series products, anti-inflammatory analgesic series products, steroid, anti-cancer drugs, cholesterol phosphate binding agents, nuclear magnetic resonance (NMR) reagents, respiratory disease drugs, central nervous system drugs, immune system regulators and weight loss drugs, as well as customized research and development and original equipment manufacturing (OEM) services. The firm distributes its products to Europe, the Americas, Asia and other markets.

Intrinsic Value
106.01 TWD
Undervaluation 31%
Intrinsic Value
Price
Back to Top